Diabetes and COVID-19: Risks, Management, and Learnings From Other National Disasters
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Evidence relating to the impact of COVID-19 in people with diabetes (PWD) is limited but continuing to emerge. PWD appear to be at increased risk of more severe COVID-19 infection, though evidence quantifying the risk is highly uncertain. The extent to which clinical and demographic factors moderate this relationship is unclear, though signals are emerging that link higher BMI and higher HbA1c to worse outcomes in PWD with COVID-19. As well as posing direct immediate risks to PWD, COVID-19 also risks contributing to worse diabetes outcomes due to disruptions caused by the pandemic, including stress and changes to routine care, diet, and physical activity. Countries have used various strategies to support PWD during this pandemic. There is a high potential for COVID-19 to exacerbate existing health disparities, and research and practice guidelines need to take this into account. Evidence on the management of long-term conditions during national emergencies suggests various ways to mitigate the risks presented by these events.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Collaborative, T. O., Williamson, E., Walker, A. J., Bhaskaran, K., Bacon, S., Bates, C., Morton, C. E., Curtis, H. J., Mehrkar, A., Evans, D., et al. (2020) · doi:10.1101/2020.05.06.20092999 · Cited by 6,674
Yang, J., Zheng, Y., Gou, X., Pu, K., Chen, Z., Guo, Q., Ji, R., Wang, H., Wang, Y., & Zhou, Y. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.017 · Cited by 4,206 · cited 2×
“meta-analysis (2) Multiple 8 3,076 Risk of diabetes in severe patients”
Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy
Onder, G., Rezza, G., & Brusaferro, S. (2020) · JAMA · doi:10.1001/jama.2020.4683 · Cited by 4,171 · cited 1×
“This could be due to demographic features of the Italian population, which include a large proportion (23%) of people aged $65 years (49).”
COVID-19 and Italy: what next?
Remuzzi, A., & Remuzzi, G. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30627-9 · Cited by 3,119
Covid-19: risk factors for severe disease and death
Jordan, R. E., Adab, P., & Cheng, K. K. (2020) · BMJ · doi:10.1136/bmj.m1198 · Cited by 1,653 · cited 1×
“Increased age, being male, hypertension, and cardiovascular comorbidities are associated with increased risks for COVID-19 severity (7) and are likely to”
Bode, B., Garrett, V., Messler, J., McFarland, R., Crowe, J., Booth, R., & Klonoff, D. C. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820924469 · Cited by 766
Grenard, J. L., Munjas, B. A., Adams, J. L., Suttorp, M., Maglione, M., McGlynn, E. A., & Gellad, W. F. (2011) · Journal of General Internal Medicine · doi:10.1007/s11606-011-1704-y · Cited by 635
Obesity and impaired metabolic health in patients with COVID-19
Stefan, N., Birkenfeld, A. L., Schulze, M. B., & Ludwig, D. S. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0364-6 · Cited by 626 · cited 4×
“plausible that BMI (8), ethnicity (9), type”
InfluentialSelf-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin
Malanda, U. L., Welschen, L. M., Riphagen, I. I., Dekker, J. M., Nijpels, G., & Bot, S. D. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005060.pub3 · Cited by 358
Computer-based diabetes self-management interventions for adults with type 2 diabetes mellitus
Pal, K., Eastwood, S. V., Michie, S., Farmer, A. J., Barnard, M. L., Peacock, R., Wood, B., Inniss, J. D., & Murray, E. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008776.pub2 · Cited by 344
Aminuddin, H. B., Jiao, N., Jiang, Y., Hong, J., & Wang, W. (2021) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2019.02.003 · Cited by 157
Psychological interventions for diabetes-related distress in adults with type 2 diabetes mellitus
Chew, B. H., Vos, R. C., Metzendorf, M.-I., Scholten, R. J., & Rutten, G. E. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011469.pub2 · Cited by 138 · cited 1×
“In the general literature, there is mixed evidence on interventions to reduce diabetes-related distress, and the vast majority of interventions tested involve face-to-face contactdan unsuitable format in the current context (39).”
Sahin, C., Courtney, K. L., Naylor, P., & E Rhodes, R. (2019) · DIGITAL HEALTH · doi:10.1177/2055207619845279 · Cited by 133
On Behalf of the Brazilian Type 1 Diabetes Study Group (BrazDiab1SG), Viana, L. V., Gomes, M. B., Zajdenverg, L., Pavin, E. J., & Azevedo, M. J. (2016) · Trials · doi:10.1186/s13063-016-1207-6 · Cited by 65
Xu, Y., Tan, D. H. Y., & Lee, J. Y. (2019) · International Journal of Clinical Practice · doi:10.1111/ijcp.13357 · Cited by 26
Cited by
Mansfield, K. E., Mathur, R., Tazare, J., Henderson, A. D., Mulick, A. R., Carreira, H., Matthews, A. A., Bidulka, P., Gayle, A., Forbes, H., et al. (2021) · The Lancet Digital Health · doi:10.1016/s2589-7500(21)00017-0 · Cited by 338
Im, J. H. B., Escudero, C., Zhang, K., Choi, D., Sivakumar, A., Booth, G. L., Sale, J., Pritlove, C., Advani, A., & Yu, C. H. (2022) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2021.10.006 · Cited by 11
Metadata
- Authors
- Hartmann-Boyce, J., Morris, E., Goyder, C., Kinton, J., Perring, J., Nunan, D., Mahtani, K., Buse, J. B., Del Prato, S., Ji, L., Roussel, R., & Khunti, K.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2020-06-16
- Volume
- 43
- Issue
- 8
- Pages
- 1695-1703
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W3035358684
- Cited by
- 251
- References
- 17
- FWCI
- 6.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.